Barriers and outcomes: TB patients co-infected with HIV accessing antiretroviral therapy in rural Zambia

被引:38
|
作者
Chileshe, Muatale [1 ,2 ]
Bond, Virginia Anne [1 ,3 ]
机构
[1] ZAMBART Project, Sch Med, Lusaka, Zambia
[2] Univ Cape Town, ZA-7925 Cape Town, South Africa
[3] LSHTM, Hlth Policy Unit, Fac Publ Hlth & Policy, London WC1E 7HT, England
来源
AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV | 2010年 / 22卷
关键词
TB; HIV; Zambia; ART; food security; RESOURCE-POOR SETTINGS; ADHERENCE; TANZANIA; PROGRAM; KISESA;
D O I
10.1080/09540121003617372
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
The vulnerabilities that underlie barriers faced by the rural poor whilst trying to access and adhere to "free'' antiretroviral treatment (ART) demand more attention. This paper highlights barriers that poor rural Zambians co-infected with tuberculosis (TB) and HIV and their households faced in accessing ART between September 2006 and July 2007, and accounts for patient outcomes by the end of TB treatment and (more sporadically) beyond October 2009. The analysis draws on findings from wider anthropological fieldwork on the converging impact of TB, HIV and food insecurity, focusing for the purpose of this paper on ethnographic case-studies of seven newly diagnosed TB patients co-infected with HIV and their six households (one household had two TB patients). Economic barriers included being pushed into deeper poverty by managing TB, rural location, absence of any external assistance, and mustering time and extended funds for transport and "special food'' during and beyond the end of TB. In the case of death, funeral costs were astronomical. Social barriers included translocation, broken marriages, a sub-ordinate household position, gender relations, denial, TB/HIV stigma and the difficulty of disclosure. Health facility barriers involved understaffing, many steps, lengthy procedures and inefficiencies (lost blood samples, electricity cuts). By the end of TB treatment, outcomes were mixed; two co-infected patients had died, three had started ART and two had yet to start ART. The three on ART underwent a striking transformation in the short term. By October 2009, two more had died and three were doing well. The study advocates nutritional support and other material support (especially transport funds) for co-infected TB patients until ART is accessed and livelihood regained. More prompt diagnosis of TB and reducing steps and increasing the reach of the ART programme in rural areas are also recommended.
引用
收藏
页码:51 / 59
页数:9
相关论文
共 50 条
  • [41] Adverse Drug Reactions to Anti-tubercular Drugs in HIV/TB Co-infected Patients.
    Chatrath, Anshul
    Shenoy, Ashok K.
    Ramapuram, John T.
    Chowta, Mukta N.
    Kamath, Ashwin
    RESEARCH JOURNAL OF PHARMACEUTICAL BIOLOGICAL AND CHEMICAL SCIENCES, 2016, 7 (02): : 1934 - 1937
  • [42] Hospital epidemiology of patients co-infected by HIV and HCV
    Thélot, B
    Pialoux, G
    Delhommeau, A
    Piroth, L
    Salmon-Céron, D
    MEDECINE ET MALADIES INFECTIEUSES, 2001, 31 (10): : 605 - 608
  • [43] The impact of HAART initiation timing on HIV-TB co-infected patients, a retrospective cohort study
    Yang, Chin-Hui
    Chen, Kuan-Jung
    Tsai, Jih-Jin
    Lin, Yu-Hui
    Cheng, Shu-Hsing
    Wang, Kwei-Feng
    Chiou, Hung-Yi
    BMC INFECTIOUS DISEASES, 2014, 14
  • [44] Diagnosis & treatment of tuberculosis in HIV co-infected patients
    Padmapriyadarsini, C.
    Narendran, G.
    Swaminathan, Soumya
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2011, 134 (06) : 850 - 865
  • [45] The impact of HAART initiation timing on HIV-TB co-infected patients, a retrospective cohort study
    Chin-Hui Yang
    Kuan-Jung Chen
    Jih-Jin Tsai
    Yu-Hui Lin
    Shu-Hsing Cheng
    Kwei-Feng Wang
    Hung-Yi Chiou
    BMC Infectious Diseases, 14
  • [46] Drug-induced hepatotoxicity among TB/HIV co-infected patients in a referral hospital, Ethiopia
    Zeleke, Abebe
    Misiker, Bethelihem
    Yesuf, Teshager Aklilu
    BMC RESEARCH NOTES, 2020, 13 (01)
  • [47] CD4+T-cell Count may not be a Useful Strategy to Monitor Antiretroviral Therapy Response in HTLV-1/HIV Co-infected Patients
    Vandormael, Alain
    Rego, Filipe
    Danaviah, Siva
    Junior Alcantara, Luiz Carlos
    Boulware, David
    de Oliveira, Tulio
    CURRENT HIV RESEARCH, 2017, 15 (03) : 225 - 231
  • [48] A new health care index predicts short term mortality for TB and HIV co-infected people
    Roen, A. O.
    Podlekareva, D.
    Miller, R. F.
    Mocroft, A.
    Panteleev, A.
    Skrahina, A.
    Miro, J. M.
    Cayla, J. A.
    Tetradov, S.
    Derisova, E.
    Furrer, H.
    Losso, M. H.
    Vassilenko, A.
    Girardi, E.
    Lundgren, J. D.
    Post, F. A.
    Kirk, O.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2020, 24 (09) : 956 - 962
  • [49] Longer Duration of HBV-Active Antiretroviral Therapy is Linked to Favorable Virological Outcome in HIV-HBV Co-infected Patients
    Lee, Tsan
    Nunez, Marina
    HIV CLINICAL TRIALS, 2009, 10 (03): : 153 - 159
  • [50] Evolution of Hematobiochemical Profiles in Newly Diagnosed HIV Patients and HIV-TB Co-Infected Patients: Correlation with Immunological and Virological Status
    Khan, Nawaid Hussain
    Verma, Chaitenya
    Beg, Mirza Masroor Ali
    Kumar, Shashi Nandar
    Kaushik, Gaurav
    Ahmad, Hafiz
    Osmonaliev, Kudaibergen
    Kumar, Vinay
    IMMUNOTARGETS AND THERAPY, 2024, 13 : 691 - 705